![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Prostate Cancer |
Free Subscription
1 BMC Urol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Prediction of biochemical recurrence after laparoscopic radical prostatectomy.
BMC Urol. 2023;23:183.
PubMed
Abstract available
Apalutamide efficacy, safety and wellbeing in older patients with advanced
prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
Br J Cancer. 2023 Nov 11. doi: 10.1038/s41416-023-02492.
PubMed
Abstract available
Years of life lost due to cancer in the United Kingdom from 1988 to 2017.
Br J Cancer. 2023;129:1558-1568.
PubMed
Abstract available
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Br J Cancer. 2023;129:1658-1666.
PubMed
Abstract available
When Is It Too Early To Start Prostate Cancer Screening? Reflections on the
PROBASE Study Using Magnetic Resonance Imaging for Men Aged 45 Yr with Elevated
Prostate-specific Antigen.
Eur Urol. 2023 Nov 13:S0302-2838(23)03212-8. doi: 10.1016/j.eururo.2023.
PubMed
Reply to Greg Shaw, John D. Kelly, and Monique J. Roobol's Letter to the Editor
re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year
Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J
Med 2023;388:
Eur Urol. 2023 Nov 8:S0302-2838(23)03218-9. doi: 10.1016/j.eururo.2023.
PubMed
Access and barriers to genomic classifiers for breast cancer and prostate cancer
in India.
Int J Cancer. 2023 Nov 14. doi: 10.1002/ijc.34784.
PubMed
Abstract available
Age at diagnosis for lung, colon, breast and prostate cancers: An international
comparative study.
Int J Cancer. 2024;154:28-40.
PubMed
Abstract available
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant
Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
J Clin Oncol. 2023 Nov 14:JCO2300339. doi: 10.1200/JCO.23.00339.
PubMed
Abstract available
Can early prostate cancer screening help address mortality disparities among
Black men?
J Natl Cancer Inst. 2023 Nov 10:djad217. doi: 10.1093.
PubMed
Ergonomic risk assessment of surgeon's position during radical prostatectomy:
Laparoscopic versus robotic approach.
J Surg Oncol. 2023;128:1453-1458.
PubMed
Abstract available
Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland
Cryoablation: A Prospective Cohort Study of Men With Intermediate-Risk Prostate
Cancer. Letter.
J Urol. 2023 Nov 14:101097JU0000000000003781. doi: 10.1097/JU.0000000000003781.
PubMed
Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland
Cryoablation: A Prospective Cohort Study of Men With Intermediate-Risk Prostate
Cancer. Reply.
J Urol. 2023 Nov 15:101097JU0000000000003782. doi: 10.1097/JU.0000000000003782.
PubMed
Genetic and biological drivers of prostate cancer disparities in Black men.
Nat Rev Urol. 2023 Nov 14. doi: 10.1038/s41585-023-00828.
PubMed
Abstract available
Disease mapping: Geographic differences in population rates of interventional
treatment for prostate cancer in Australia.
PLoS One. 2023;18:e0293954.
PubMed
Abstract available
Incidence and risk factors of prostate cancer among the Northern and Eastern
parts of the United Arab Emirates population.
Prostate. 2023 Nov 15:e24637. doi: 10.1002/pros.24637.
PubMed
Abstract available
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations
for improved survival and treatment effectiveness.
Prostate. 2023 Nov 14. doi: 10.1002/pros.24650.
PubMed
Abstract available
Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are
Early-phase Clinical Trials.
Radiology. 2023;309:e231177.
PubMed
National long-term survival estimates after radical prostatectomy for prostate
cancer.
Urology. 2023 Nov 9:S0090-4295(23)00987-1. doi: 10.1016/j.urology.2023.
PubMed
Abstract available
Thank you for your interest in scientific medicine.